November 4, 2025
Swiss President Addresses Recognizing Palestine
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
November 4, 2025
Switzerland says conditions to recognize Palestine haven’t been met
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
November 21, 2025
Epinephrine Market Projected to Witness a Growth of US $4.11 Billion by 2029 | The Business Research Company
Neutral
EIN Presswire
November 21, 2025
Botanical Supplements Market Set to Surge with 10.3% CAGR, Reaching USD 145.16 Billion by 2034
Indeterminate
GlobeNewswire, Inc.
November 21, 2025
GMP Drug Substance Market to Reach USD 4.64 Billion by 2034, Growing at 6.14% CAGR
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Noema Pharma Announces Phase 2a Study Results with Cendifensine in Women with Vasomotor Symptoms (Hot Flashes) Due to Menopause
Indeterminate
GlobeNewswire, Inc.
October 29, 2025
Pharmaceutical Market to Reach USD 3,033.21 Billion by 2034 Driven by Rising Geriatric Population
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
High Concentration mAb Products Market Advancing Precision Biopharmaceutical Therapeutics – Towards Healthcare
Indeterminate
GlobeNewswire, Inc.
November 5, 2025
Telix to Participate in UBS and Jefferies Global Healthcare Conferences
Indeterminate
GlobeNewswire, Inc.
November 5, 2025
AVEROA Receives UK MHRA Approval for XOANACYL®, an Oral Therapy Targeting Key Complications of Chronic Kidney Disease (CKD)
Indeterminate
GlobeNewswire, Inc.
November 4, 2025
Evolve Senior Living at Lake Zurich to Host Fall Fest Featuring Ribbon Cutting with the LZ Area Chamber of Commerce
Neutral
EIN Presswire
November 5, 2025
Protein Engineering Market to Grow at 16.27% CAGR by 2034, Driven by Rising Outsourcing and Expanding Healthcare Applications
Indeterminate
GlobeNewswire, Inc.
October 27, 2025
Switzerland’s Novartis Lands Deal to Acquire U.S. Avidity Biosciences
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
November 4, 2025
FIVE-YEAR BRAIN HEALTH ACTION PLAN TO POWER ECONOMIC GROWTH LAUNCHED ACROSS AFRICA
Neutral
EIN Presswire
November 4, 2025
Nxera Pharma to Host R&D Day 2025
Indeterminate
GlobeNewswire, Inc.